Thomas Linn - Concepedia

Author

Thomas Linn

Justus-Liebig-Universität Gießen ORCID

Also Known As

K Koysombat, Linn, Thomas, M Khan, N. Oakes, P. Pozzilli, S Dindyal, T Linn, T. Linn, T. Linn�, THOMAS LINN

166

Publications

6.7K

Citations

H-Index

127

Concepts

All Affiliations

Justus-Liebig-Universität Gießen Universitätsklinikum Gießen und Marburg Heidelberg University University Hospital Heidelberg University Medical Centre Mannheim

About

Thomas Linn is an author at Justus-Liebig-Universität Gießen specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	3.5K
2	Health Sciences	13	15	707
3	Engineering	4	4	119
4	Natural Sciences	2	2	35
5	Public Health	1	1	86

Thomas Linn

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Rüdiger Göke, H. C. Fehmann, Thomas Linn, Journal of Biological Chemistry Cross-linking ExperimentsGlycobiologyPeptide ScienceCytoskeletonCellular Physiology	1993	834
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Carel W. le Roux, Arne Astrup, Ken Fujioka, The Lancet ObesityMetabolic SyndromeNutritionDiabetes ManagementLiraglutide Versus Placebo	2017	813
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins Triantafyllos Chavakis, Angelika Bierhaus, Nadia Al‐Fakhri, The Journal of Experimental Medicine	2003	573
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial Reinhard G. Bretzel, Ulrike A. Nuber, Wolfgang Landgraf, The Lancet Metabolic SyndromeDiabetes ManagementBasal Insulin GlargineMedicineDiabetes	2008	305
Effect of long-term dietary protein intake on glucose metabolism in humans Thomas Linn, Budi Santosa, Dietrich Grönemeyer, Diabetologia ObesityNutritionMetabolic SyndromeLong-term Dietary ProteinGlucose Metabolism	2000	245
Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells Shirui Mao, Oliver Germershaus, Dagmar Fischer, Pharmaceutical Research Cell-based Drug DeliveryPolymer-drug ConjugateDrug Delivery SystemsNano-drug DeliveryBiomedical Engineering	2005	161
Vascular Endothelial Growth Factor Increases Functional β-Cell Mass by Improvement of Angiogenesis of Isolated Human and Murine Pancreatic Islets Yi Lai, Darius Schneider, André Kidszun, Transplantation	2005	147
Angiogenic capacity of endothelial cells in islets of Langerhans Thomas Linn, Karl Schneider, H. P. Hammes, The FASEB Journal Endothelial CellsImmunologyGlucose HomeostasisTissue TransplantationBiomedical Engineering	2003	102
Temperature‐dependent regulation of d‐<i>cis</i>‐[<sup>3</sup>H]diltiazem binding to Ca<sup>2+</sup> channels by 1,4‐dihydropyridine channel agonists and antagonists Hartmut Glossmann, Thomas Linn, Martin Rombusch, FEBS Letters	1983	95
Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. Thomas Linn, Rudolf Geyer, S Prassek, The Journal of Clinical Endocrinology & Metabolism NutritionAdult-onset Insulin DependentNp FoodInsulin SignalingObesity	1996	87

Page 1